NCT04254250

Brief Summary

This study will be conducted at Research Institute of Traumatology and Orthopedics (NRITO) n.a. Ya.L.Tsivyan, Novosibirsk, Russia. The current study is prospective observational study to evaluate the efficacy of preoperative estimation of disc herniation recurrence among patients with lumbar disc herniation using predictive mathematical model at terms 3 years postoperatively . It is expected to enroll 350 patients aged 18-70 with lumbar disc herniation. Risk estimation of disc herniation recurrence will be evaluated preoperatively, then patient will undergo conventional microdiscectomy. Postoperative eximanation will include Visits every 6-months during 3 years to evaluate clinical outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
386

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2020

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 1, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 5, 2020

Completed
5 days until next milestone

Study Start

First participant enrolled

February 10, 2020

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 10, 2023

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2026

Completed
Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

3.5 years

First QC Date

February 1, 2020

Last Update Submit

February 25, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Reherniation rate

    Rate of lumbar disc reherniation, symptomatic presence of disc herniation confirmed by MRI at the previously operated level and side

    at 3 years follow-up term postoperatively

Secondary Outcomes (4)

  • Improvement of Oswestry Disability Index (ODI)

    6, 12, 18, 24, 30, 36 months follow up

  • Improvement of Visual analog scale (VAS) leg pain intensity

    6, 12, 18, 24, 30, 36 months follow up

  • Change from baseline in EQ-5D (EuroQl - 5 dimensional)

    6, 12, 18, 24, 30, 36 months follow up

  • HTI Item (from SF-36)

    6, 12, 18, 24, 30, 36 months follow up

Study Arms (2)

High risk recurrence group

Due to preoperative risk estimation each patient will be assigned to one of two groups - with high risk and low risk.

Diagnostic Test: Preoperative risk estimation of disc herniation recurrence

Low risk recurrence group

Due to preoperative risk estimation each patient will be assigned to one of two groups - with high risk and low risk.

Diagnostic Test: Preoperative risk estimation of disc herniation recurrence

Interventions

Risk estimation of disc herniation recurrence will be evaluated preoperatively, depend on the risk significance each patient will be assigned to one of two groups - with high risk and low risk. Then each patient will undergo conventional one-level microdiscectomy.

High risk recurrence groupLow risk recurrence group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Adult patients with radicular leg pain with or without back pain secondary to single level disc herniation with neural compression confirmed on MRI and symptoms persisting for at least four weeks prior to surgery

You may qualify if:

  • \- Age 18 to 60 years;
  • Single level lumbar disc herniation with neural compression confirmed on MRI at one level of L4-L5 or L5-S1;
  • Radicular leg pain with or without back pain;
  • Symptoms persisting for at least four weeks prior to surgery;
  • Given written Informed Consent;
  • Able and agree to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements;
  • Visual Analogue Scale score at least 40/100 at baseline.

You may not qualify if:

  • More than one symptomatic level requiring multilevel surgical decompression
  • Stenosis any etiology at the same level;
  • Spondylolisthesis any etiology at the same level;
  • Prior lumbar spinal surgery at any level;
  • Other non-degenerative spinal conditions (e.g. infectious, traumatic, metabolic, inflammatory, neoplastic, structural or other pathology) that may have an impact on subject safety, wellbeing or the intent and conduct of the study
  • Concurrent participation in another clinical study that may confound study results.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Priorov National Medical Research Center of Traumatology and Orthopedics

Moscow, 127299, Russia

Location

Novosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan

Novosibirsk, 630091, Russia

Location

MeSH Terms

Conditions

Intervertebral Disc Displacement

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Years
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2020

First Posted

February 5, 2020

Study Start

February 10, 2020

Primary Completion

August 10, 2023

Study Completion

February 25, 2026

Last Updated

February 27, 2026

Record last verified: 2026-02

Locations